Histological Risk Factors for Lymph Node Metastasis in pT1 Colorectal Cancer: Does Submucosal Invasion Depth Really Matter?

Bing Yue , Mei Jia , Rui Xu , Guang-yong Chen , Mu-lan Jin

Current Medical Science ›› : 1 -10.

PDF
Current Medical Science ›› : 1 -10. DOI: 10.1007/s11596-024-2926-7
Original Article

Histological Risk Factors for Lymph Node Metastasis in pT1 Colorectal Cancer: Does Submucosal Invasion Depth Really Matter?

Author information +
History +
PDF

Abstract

Objective

After endoscopic resection of colorectal cancer with submucosal invasion (pT1 CRC), additional surgical treatment is recommended if deep submucosal invasion (DSI) is present. This study aimed to further elucidate the risk factors for lymph node metastasis (LNM) in patients with pT1 CRC, especially the effect of DSI on LNM.

Methods

Patients with pT1 CRC who underwent lymph node dissection were selected. The Chi-square test and multivariate logistic regression were used to analyze the relationship between clinicopathological characteristics and LNM. The submucosal invasion depth (SID) was measured via 4 methods and analyzed with 3 cut-off values.

Results

Twenty-eight of the 239 patients presented with LNM (11.7%), and the independent risk factors for LNM included high histological grade (P=0.003), lymphovascular invasion (LVI) (P=0.004), intermediate to high budding (Bd 2/3) (P=0.008), and cancer gland rupture (CGR) (P=0.008). Moreover, the SID, width of submucosal invasion (WSI), and area of submucosal invasion (ASI) were not significantly different. When one, two, three or more risk factors were identified, the LNM rates were 1.1% (1/95), 12.5% (7/56), and 48.8% (20/41), respectively.

Conclusion

Indicators such as the SID, WSI, and ASI are not risk factors for LNM and are subjective in their measurement, which renders them relatively inconvenient to apply in clinical practice. In contrast, histological grade, LVI, tumor budding and CGR are relatively straightforward to identify and have been demonstrated to be statistically significant. It would be prudent to focus on these histological factors rather than subjective measurements.

Cite this article

Download citation ▾
Bing Yue, Mei Jia, Rui Xu, Guang-yong Chen, Mu-lan Jin. Histological Risk Factors for Lymph Node Metastasis in pT1 Colorectal Cancer: Does Submucosal Invasion Depth Really Matter?. Current Medical Science 1-10 DOI:10.1007/s11596-024-2926-7

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

YoshidaN, NaitoY, InadaY, et al. . Cross-national analysis about the difference of histopathological management in Tis and T1 colorectal cancer between Japan and Korea. J Anus Rectum Colon, 2019, 3(1): 18-26

[2]

HaggittRC, GlotzbachRE, SofferEE, et al. . Prognostic factors in colorectal carcinomas arising in adenomas: implications for lesions removed by endoscopic polypectomy. Gastroenterology, 1985, 89(2): 328-336

[3]

IchimasaK, KudoSE, MiyachiH, et al. . Risk stratification of T1 colorectal cancer metastasis to lymph nodes: current status and perspective. Gut Liver, 2021, 15(6): 818-826

[4]

TianY, RongL, MaY. Surgical resection after endoscopic resection in patients with T1 colorectal cancer: a meta-analysis. Int J Colorectal Dis, 2021, 36(3): 457-466

[5]

KitajimaK, FujimoriT, FujiiS, et al. . Correlations between lymph node metastasis and depth of submucosal invasion in submucosal invasive colorectal carcinoma: a Japanese collaborative study. J Gastroenterol, 2004, 39(6): 534-543

[6]

SuhJH, HanKS, KimBC, et al. . Predictors for lymph node metastasis in T1 colorectal cancer. Endoscopy, 2012, 44(6): 590-595

[7]

TateishiY, NakanishiY, TaniguchiH, et al. . Pathological prognostic factors predicting lymph node metastasis in submucosal invasive (T1) colorectal carcinoma. Mod Pathol, 2010, 23(8): 1068

[8]

HashiguchiY, MuroK, SaitoY, et al. . Japanese Society for Cancer of the Colon and Rectum, Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int J Clin Oncol, 2020, 25(1): 1-42

[9]

Glynne-JonesR, WyrwiczL, TiretE, et al. . Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol, 2018, 29(Suppl4): iv263

[10]

Pimentel-NunesP, LibânioD, BastiaansenBAJ, et al. . Endoscopic submucosal dissection for superficial gastrointestinal lesions: European Society of Gastrointestinal Endoscopy (ESGE) Guideline — Update 2022. Endoscopy, 2022, 54(6): 591-622

[11]

BensonAB, VenookAP, Al-HawaryMM, et al. . Rectal Cancer, version 2.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 2018, 16(7): 874-901

[12]

ParkCH, YangDH, KimJW, et al. . Clinical practice guideline for endoscopic resection of early gastrointestinal cancer. Clin Endosc, 2020, 53(2): 142-166

[13]

LugliA, KirschR, AjiokaY, et al. . Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016. Mod Pathol, 2017, 30(9): 1299-1311

[14]

DeboveC, SvrcekM, DumontS, et al. . Is the assessment of submucosal invasion still useful in the management of early rectal cancer? A study of 91 consecutive patients. Colorectal Dis, 2017, 19(1): 27-37

[15]

RönnowCF, ArthurssonV, TothE, et al. . Lymphovascular infiltration, not depth of invasion, is the critical risk factor of metastases in early colorectal cancer: retrospective populationbased cohort study on prospectively collected data, including validation. Ann Surg, 2022, 275(1): e148-e154

[16]

YoshiiS, NojimaM, NoshoK, et al. . Factors associated with risk for colorectal cancer recurrence after endoscopic resection of T1 tumors. Clin Gastroenterol Hepato, 2014, 12(2): 292

[17]

TamaruY, OkaS, TanakaS, et al. . Long-term outcomes after treatment for T1 colorectal carcinoma: a multicenter retrospective cohort study of Hiroshima GI Endoscopy Research Group. J Gastroenterol, 2017, 52(11): 1169-1179

[18]

OzekiT, ShimuraT, OzekiT, et al. . The risk analyses of lymph node metastasis and recurrence for submucosal invasive colorectal cancer: novel criteria to skip completion surgery. Cancers (Basel), 2022, 14(3): 822

[19]

HanJ, HurH, MinBS, et al. . Predictive factors for lymph node metastasis in submucosal invasive colorectal carcinoma: a new proposal of depth of invasion for radical surgery. World J Surg, 2018, 42(8): 2635-2641

[20]

DykstraMA, GimonTI, RonksleyPE, et al. . Classic and novel histopathologic risk factors for lymph node metastasis in T1 colorectal cancer: a systematic review and meta-analysis. Dis Colon Rectum, 2021, 64(9): 1139-1150

[21]

TohEW, BrownP, MorrisE, et al. . Area of submucosal invasion and width of invasion predicts lymph node metastasis in pT1 colorectal cancers. Dis Colon Rectum, 2015, 5(4): 393-400

[22]

UenoH, MochizukiH, HashiguchiY, et al. . Risk factors for an adverse outcome in early invasive colorectal carcinoma. Gastroenterology, 2004, 127(2): 385-394

[23]

Endoscopic Classification Review Group.. Update on the paris classification of superficial neoplastic lesions in the digestive tract. Endoscopy, 2005, 37(6): 570-578

[24]

WHO Classification of Tumours Editorial Board.. Digestive System Tumours, 2019fifthGenevaWorld Health Organization

[25]

KikuchiR M, TakagiK, et al. . Management of early invasive colorectal cancer. Risk of recurrence and clinical guidelines. Dis Colon Rectum, 1995, 38(12): 1286-1295

[26]

OishiK, ItoT, SakonishiD, et al. . Cancer gland rupture as a potential risk factor for lymph node metastasis in early colorectal adenocarcinoma with deep submucosal invasion. Histopathology, 2020, 76(4): 603-612

[27]

AizawaD, SuginoT, OishiT, et al. . The essential problem of over-measuring the depth of submucosal invasion in pT1 colorectal cancer. Virchows Arch, 2022, 480(2): 323-333

[28]

SuzukiT, SadahiroS, MukoyamaS, et al. . Risk of lymph node and distant metastases in patients with early invasive colorectal cancer classified as Haggitt’s level 4 invasion: image analysis of submucosal layer invasion. Dis Colon Rectum, 2003, 46(2): 203-208

[29]

YimK, WonDD, LeeIK, et al. . Novel predictors for lymph node metastasis in submucosal invasive colorectal carcinoma. World J Gastroenterol, 2017, 23(32): 5936-5944

[30]

NCCN clinical practice guidelines in oncology: colon cancer. National Comprehensive Cancer Network. Available from: http://www.nccn.org/professionals/physician_gls/pdf/colon.pdf.

[31]

YasueC, ChinoA, TakamatsuM, et al. . Pathological risk factors and predictive endoscopic factors for lymph node metastasis of T1 colorectal cancer: a single-center study of 846 lesions. J Gastroenterol, 2019, 54(8): 708-717

[32]

QuirkeP, RisioM, LambertR, et al. . Quality assurance in pathology in colorectal cancer screening and diagnosis — European recommendations. Virchows Arch, 2011, 458(1): 1-19

[33]

HaboubiN, SalmoE. Are we accurately measuring the depth of the submucosal invasion in early colorectal cancer by equating the Kikuchi submucosa levels with distances measured in fractions of a millimetre?. Colorectal Dis, 2013, 15(7): 775-777

[34]

KimuraR, FujimoriT, IchikawaK, et al. . Desmoplastic reaction in biopsy specimens of early colorectal cancer: a Japanese prospective multicenter study. Pathol Int, 2012, 62(8): 525-531

[35]

ChoiJY, JungSA, ShimKN, et al. . The Korean ESD Study Group, Meta-analysis of predictive clinicopathologic factors for lymph node metastasis in patients with early colorectal carcinoma. J Korean Med Sci, 2015, 30(4): 398-406

[36]

KawachiH, EishiY, UenoH, et al. . A three-tier classification system based on the depth of submucosal invasion and budding/sprouting can improve the treatment strategy for T1 colorectal cancer: a retrospective multicenter study. Mod Pathol, 2015, 28(6): 872-879

[37]

ZwagerLW, BastiaansenBAJ, MontazeriNSM, et al. . Deep submucosal invasion is not an independent risk factor for lymph node metastasis in T1 colorectal cancer: a meta-analysis. Gastroenterology, 2022, 163(1): 174-189

[38]

KouyamaY, KudoSE, MiyachiH, et al. . Practical problems of measuring depth of submucosal invasion in T1 colorectal carcinomas. Int J Colorectal Dis, 2016, 31(1): 137-146

[39]

ZhangQ, WangL, HuangD, et al. . Pathological risk factors for lymph node metastasis in patients with submucosal invasive colorectal carcinoma. Cancer Manag Res, 2019, 30(11): 1107-1114

[40]

CraccoN, TodaroV, PedrazziG, et al. . The risk of lymph node metastasis in T1 colorectal cancer: new parameters to assess the degree of submucosal invasion. Int J Colorectal Dis, 2021, 36(1): 41-45

[41]

KojimaM, PuppaG, KirschR, et al. . Blood and lymphatic vessel invasion in pT1 colorectal cancer: an international concordance study. J Clin Pathol, 2015, 68(8): 628-632

[42]

WadaH, ShiozawaM, SuganoN, et al. . Lymphatic invasion identified with D2-40 immunostaining as a risk factor of nodal metastasis in T1 colorectal cancer. Int J Clin Oncol, 2013, 18(6): 1025-1031

[43]

RogersAC, WinterDC, HeeneyA, et al. . Systematic review and meta-analysis of the impact of tumour budding in colorectal cancer. Br J Cancer, 2016, 115(7): 831-840

AI Summary AI Mindmap
PDF

145

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/